Medical professionals worldwide are transforming their approach to antidepressant discontinuation, finally acknowledging the debilitating withdrawal symptoms millions of patients frequently endure.

Historically misdiagnosed as psychiatric relapses, discontinuation syndrome is prompting updated clinical guidelines centered on hyper-gradual tapering strategies.

Physicians now emphasize personalized, micro-dose reductions over extended months, offering patients safer transitions when concluding their treatments.